keyword
MENU ▼
Read by QxMD icon Read
search

antimüllerian

keyword
https://www.readbyqxmd.com/read/28089575/association-of-uterine-fibroids-and-pregnancy-outcomes-after-ovarian-stimulation-intrauterine-insemination-for-unexplained-infertility
#1
Aaron K Styer, Susan Jin, Dan Liu, Baisong Wang, Alex J Polotsky, Mindy S Christianson, Wendy Vitek, Lawrence Engmann, Karl Hansen, Robert Wild, Richard S Legro, Christos Coutifaris, Ruben Alvero, Randal D Robinson, Peter Casson, Gregory M Christman, Alicia Christy, Michael P Diamond, Esther Eisenberg, Heping Zhang, Nanette Santoro
OBJECTIVE: To investigate the association of non-cavity-distorting uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination (OS-IUI) in couples with unexplained infertility. DESIGN: Secondary analysis from a prospective, randomized, multicenter clinical trial investigating fertility outcomes after OS-IUI. SETTING: Reproductive Medicine Network clinical sites. PATIENT(S): Nine hundred couples with unexplained infertility who participated in the Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS) clinical trial...
January 12, 2017: Fertility and Sterility
https://www.readbyqxmd.com/read/28089574/does-preoperative-antim%C3%A3-llerian-hormone-level-influence-postoperative-pregnancy-rate-in-women-undergoing-surgery-for-severe-endometriosis
#2
Emanuela Stochino-Loi, Basma Darwish, Oana Mircea, Salma Touleimat, Jenny-Claude Millochau, Carole Abo, Stefano Angioni, Horace Roman
OBJECTIVE: To compare postoperative pregnancy rates as they relate to presurgery antimüllerian hormone (AMH) level in patients with stage 3 and 4 endometriosis. DESIGN: Retrospective comparative study using data prospectively recorded in the North-West Inter-Regional Female Cohort for Patients with Endometriosis (CIRENDO) database. SETTING: University tertiary referral center. PATIENT(S): One hundred eighty patients with stage 3 and 4 endometriosis and pregnancy intention, managed from June 2010 to March 2015, were divided into two groups according to their preoperative AMH levels: group A (AMH ≥2 ng/mL) and group B (AMH <2 ng/mL)...
January 12, 2017: Fertility and Sterility
https://www.readbyqxmd.com/read/28066836/a-comparative-study-on-the-results-of-agonist-and-antagonist-protocols-based-on-serum-amh-levels-in-patients-undergoing-intracytoplasmic-sperm-injection
#3
Fatemeh Nikmard, Behrouz Aflatoonian, Elham Hosseini, Abbas Aflatoonian, Mehrdad Bakhtiyari, Reza Aflatoonian
BACKGROUND: Serum concentrations of antimullerian hormone (AMH) correlate with ovarian response during assisted reproduction treatment (ART) cycles. OBJECTIVE: This retrospective study attempted to evaluate the selection of ovarian stimulation protocols based on serum AMH levels in patients and its impact on the results of ART. MATERIALS AND METHODS: Based on AMH levels, the patients with tubal factor infertility were divided in three groups of normal, low and high AMH levels...
December 2016: International Journal of Reproductive Biomedicine (Yazd, Iran)
https://www.readbyqxmd.com/read/28036005/bisphenol-a-and-ovarian-reserve-among-infertile-women-with-polycystic-ovarian-syndrome
#4
Wei Zhou, Fang Fang, Wenting Zhu, Zi-Jiang Chen, Yanzhi Du, Jun Zhang
To better understand possible effects of bisphenol A (BPA) exposure on ovarian reserve in women with polycystic ovary syndrome (PCOS), we measured creatinine adjusted urinary BPA (BPA_Cre) concentrations and used regression models to evaluate the association between urinary BPA level and antral follicle count (AFC), antimullerian hormone (AMH), day-3 follicle stimulating hormone levels (FSH) and inhibin B (INHB) in 268 infertile women diagnosed with PCOS. BPA was detected in all women with a median concentration of 2...
December 27, 2016: International Journal of Environmental Research and Public Health
https://www.readbyqxmd.com/read/27912901/individualized-versus-conventional-ovarian-stimulation-for-in%C3%A2-vitro-fertilization-a-multicenter-randomized-controlled-assessor-blinded-phase-3-noninferiority-trial
#5
Anders Nyboe Andersen, Scott M Nelson, Bart C J M Fauser, Juan Antonio García-Velasco, Bjarke M Klein, Joan-Carles Arce
OBJECTIVE: To compare the efficacy and safety of follitropin delta, a new human recombinant FSH with individualized dosing based on serum antimüllerian hormone (AMH) and body weight, with conventional follitropin alfa dosing for ovarian stimulation in women undergoing IVF. DESIGN: Randomized, multicenter, assessor-blinded, noninferiority trial (ESTHER-1). SETTING: Reproductive medicine clinics. PATIENT(S): A total of 1,329 women (aged 18-40 years)...
November 22, 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27887709/impact-of-tamoxifen-therapy-on-fertility-in-breast-cancer-survivors
#6
Lisa M Shandley, Jessica B Spencer, Amy Fothergill, Ann C Mertens, Amita Manatunga, Elisavet Paplomata, Penelope P Howards
OBJECTIVE: To determine whether tamoxifen use is associated with decreased ovarian reserve and decreased likelihood of having a child after a breast cancer diagnosis, using data from the Furthering Understanding of Cancer, Health, and Survivorship in Adult (FUCHSIA) Women Study. DESIGN: Population-based cohort study. SETTING: Not applicable. PATIENT(S): Three hundred ninety-seven female breast cancer survivors aged 22-45 years whose cancer was diagnosed between ages 20 and 35 years and who were at least 2 years after diagnosis; 108 survivors also participated in a clinic visit...
January 2017: Fertility and Sterility
https://www.readbyqxmd.com/read/27842995/antim%C3%A3-llerian-hormone-levels-and-cardiometabolic-risk-in-young-women-with-polycystic-ovary-syndrome
#7
Rebecca A Feldman, Kathleen O'Neill, Samantha F Butts, Anuja Dokras
OBJECTIVE: To determine the association between antimüllerian hormone (AMH) levels and metabolic syndrome (MetSyn) in young women with polycystic ovary syndrome (PCOS). DESIGN: Cross-sectional study. SETTING: Academic PCOS center. PATIENT(S): A total of 252 women aged 18-46 years with PCOS. INTERVENTION: None. MAIN OUTCOME MEASURE(S): Association of AMH with markers of cardiometabolic risk and MetSyn...
January 2017: Fertility and Sterility
https://www.readbyqxmd.com/read/27793387/effect-of-pregnancy-associated-plasma-protein-a-papp-a-single-nucleotide-polymorphisms-on-the-level-and-activity-of-papp-a-and-the-hormone-profile-in-fluid-from-normal-human-small-antral-follicles
#8
Jane Alrø Bøtkjær, Tanni Borgbo, Søren Kløverpris, Pernille Rimmer Noer, Claus Oxvig, Claus Yding Andersen
OBJECTIVE: To reveal a possible relationship between two single nucleotide polymorphisms (SNPs) in PAPP-A-1224 (rs7020782) and 327 (rs12375498)-and the level and activity of PAPP-A in follicular fluid (FF) of human small antral follicles, and to analyze the intrafollicular hormone levels. DESIGN: Laboratory investigation. SETTING: University hospital. PATIENT(S): Fifty volunteer women who contributed a total of 210 samples of FF from normal small antral follicles...
December 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27751408/comparison-of-early-postoperative-decline-of-serum-antim%C3%A3-llerian-hormone-levels-after-unilateral-laparoscopic-ovarian-cystectomy-between-patients-categorized-according-to-histologic-diagnosis
#9
Sungwook Chun, Hyun Jin Cho, Yong Il Ji
OBJECTIVE: To evaluate the change of ovarian reserve after unilateral laparoscopic ovarian cystectomy (LOC) in the early postoperative period between patients divided according to histologic diagnosis of cyst type. MATERIALS AND METHODS: Sixty-five patients who were undergoing unilateral LOC for benign ovarian disease were included in this study. All participants were divided into three groups according to histologic diagnosis: endometrioma (n=26), mature teratoma (n=24), and other benign cyst (n=15)...
October 2016: Taiwanese Journal of Obstetrics & Gynecology
https://www.readbyqxmd.com/read/27692436/new-automated-antim%C3%A3-llerian-hormone-assays-are-more-reliable-than-the-manual-assay-in-patients-with-reduced-antral-follicle-count
#10
Teddy Tadros, Bruno Tarasconi, Jean Nassar, Jean-Luc Benhaim, Joëlle Taieb, Renato Fanchin
OBJECTIVE: To compare the strength of the relationship between antral follicle count (AFC) and serum antimüllerian hormone (AMH) concentrations obtained with two automated and one manual AMH assays in three different AFC populations. DESIGN: Prospective cohort study. SETTING: University-affiliated IVF-ET center. PATIENT(S): Frozen-thawed serum samples of 211 assisted conception candidates, aged 24-43 years. INTERVENTION(S): Serum AMH was measured using one manual (AMH Gen II) and two fully automated (Access AMH and Elecsys AMH) assays...
December 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27678030/direct-vitamin-d3-actions-on-rhesus-macaque-follicles-in-three-dimensional-culture-assessment-of-follicle-survival-growth-steroid-and-antim%C3%A3-llerian-hormone-production
#11
Jing Xu, Jon D Hennebold, David B Seifer
OBJECTIVE: To investigate the direct actions of active 1,25-dihydroxy vitamin D3 (VD3) upon primate follicular development at specific stages of folliculogenesis. DESIGN: Secondary preantral follicles were isolated from rhesus monkeys ovaries, encapsulated in alginate, and cultured for 40 days. Follicles were randomly assigned to experimental groups of control, low-dose VD3 (LVD3; 25 pg/mL), and high-dose VD3 (HVD3; 100 pg/mL). SETTING: National primate research center...
December 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27565260/longitudinal-changes-in-maternal-serum-concentrations-of-antim%C3%A3-llerian-hormone-in-individual-women-during-conception-cycles-and-early-pregnancy
#12
Kristina Hamilton, Narelle Hadlow, Peter Roberts, Patricia Sykes, Allison McClements, Jacqui Coombes, Phillip Matson
OBJECTIVE: To study antimüllerian hormone (AMH) from gestation week 0-7. DESIGN: Longitudinal study of 85 pregnant women with AMH and reproductive hormones sampled during conception cycle and early pregnancy until week 7. SETTING: Fertility clinic. PATIENT(S): Of 85 pregnant women, 69 had a singleton pregnancy, 1 a twin pregnancy, and 15 had a nonviable pregnancy (3 chemical pregnancies, 11 miscarriages, and 1 blighted ovum)...
November 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27475411/antim%C3%A3-llerian-hormone-among-women-with-and-without-type-1-diabetes-the-epidemiology-of-diabetes-interventions-and-complications-study-and-the-michigan-bone-health-and-metabolism-study
#13
Catherine Kim, Carrie Karvonen-Gutierrez, Shengchun Kong, Valerie Arends, Michael Steffes, Daniel S McConnell, John F Randolph, Siobán D Harlow
OBJECTIVE: To compare concentrations of antimüllerian hormone (AMH) in women with and without type 1 diabetes. DESIGN: Cross-sectional analysis of longitudinal studies, adjusting for repeated measures. SETTING: Not applicable. PATIENT(S): Women aged 30-45 years who had not undergone oophorectomy, hysterectomy, or natural menopause at the time of AMH measurement were included (n = 376 in the Michigan Bone Health and Metabolism Study and n = 321 in the Epidemiology of Interventions and Complications Study)...
November 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27465716/low-amh-levels-as-a-marker-of-reduced-ovarian-reserve-in-young-women-affected-by-down-s-syndrome
#14
Daniela Romualdi, Caterina Proto, Simona De Cicco, Valentina Immediata, Concetta Barone, Corrado Romano, Antonio Lanzone
OBJECTIVE: Women with Down's syndrome (DS) experience menopause earlier than healthy women and are twice as likely to undergo premature ovarian insufficiency. Menopause accelerates cognitive decline and is associated with a twofold increased mortality risk in DS women. Nonetheless, no previous studies investigated the ovarian reserve in this population. The aim of the present study was to evaluate the circulating antimullerian hormone (AMH) levels in DS women with regular menstrual cycles, in comparison with those observed in an age-matched group of healthy women...
July 25, 2016: Menopause: the Journal of the North American Menopause Society
https://www.readbyqxmd.com/read/27430206/high-cytokine-expression-and-reduced-ovarian-reserve-in-patients-with-hodgkin-lymphoma-or-non-hodgkin-lymphoma
#15
Roberto Paradisi, Rossella Vicenti, Maria Macciocca, Renato Seracchioli, Stefania Rossi, Raffaella Fabbri
OBJECTIVE: To investigate the ovarian reserve in female lymphoma patients and the potential relationships with the cytokine network. DESIGN: Age-matched control study. SETTING: Women's university hospital. PATIENT(S): Seventy-three lymphoma patients (57 with classic Hodgkin lymphoma [HL] and 16 with non-Hodgkin lymphoma [NHL]), approaching our center for ovarian tissue cryopreservation (study group) were compared with 25 age-matched healthy volunteers (control group)...
July 15, 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27430205/towards-improving-analysis-and-interpretation-of-antim%C3%A3-llerian-hormone-in-women
#16
Richard A Anderson
No abstract text is available yet for this article.
July 15, 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27382235/evaluation-of-dual-trigger-with-gonadotropin-releasing-hormone-agonist-and-human-chorionic-gonadotropin-in-improving-oocyte-maturity-rates-a-prospective-randomized-study
#17
Nalini Mahajan, Shilpa Sharma, Puneet Rana Arora, Shalu Gupta, Kumkum Rani, Padmaja Naidu
BACKGROUND: Mature oocytes are prerequisite for achieving the process of in vitro fertilization. Human chorionic gonadotropin (hCG) is the standard trigger used for stimulating ovulation but is associated with ovarian hyperstimulation syndrome (OHSS). Gonadotropin-releasing hormone agonist trigger achieves oocyte maturation and lowers the incidence of OHSS, but it has limitations of higher pregnancy loss rate and miscarriage rates. Coadministration of both hormones is found to improve the pregnancy rates and the number of mature oocytes retrieved...
April 2016: Journal of Human Reproductive Sciences
https://www.readbyqxmd.com/read/27371114/higher-rates-of-aneuploidy-in-blastocysts-and-higher-risk-of-no-embryo-transfer-in-recurrent-pregnancy-loss-patients-with-diminished-ovarian-reserve-undergoing-in%C3%A2-vitro-fertilization
#18
Lora K Shahine, Lorna Marshall, Julie D Lamb, Lee R Hickok
OBJECTIVE: To study the prediction of aneuploidy rate in blastocysts from patients with recurrent pregnancy loss (RPL) on the basis of ovarian reserve testing. DESIGN: Prospective cohort analysis. SETTING: Private, university-affiliated fertility clinic. PATIENT(S): A total of 239 patients with RPL, defined as two or more clinical miscarriages, were screened for inclusion. One hundred two (102) cycles in patients with unexplained RPL resulted in at least one euploid embryo transferred...
October 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27362611/variation-in-circulating-antim%C3%A3-llerian-hormone-precursor-during-the-periovulatory-and-acute-postovulatory-phases-of-the-human-ovarian-cycle
#19
Michael W Pankhurst, Yih Harng Chong
OBJECTIVE: To determine whether the relative quantity of circulating AMH precursor (proAMH) declines relative to levels of the active form (AMHN,C) in the periovulatory phase of the ovarian cycle. DESIGN: Longitudinal study. SETTING: Local community. PATIENT(S): Sixteen women aged between 18 to 30 years with regular menstrual cycles between 25 to 35 days long. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Serum concentrations of proAMH and total AMH (proAMH and AMHN,C combined) measured by immunoassay, with relative levels of proAMH expressed as the AMH prohormone index (API = [ProAMH]/[Total AMH] × 100)...
June 27, 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27351446/quantifying-the-intraindividual-variation-of-antim%C3%A3-llerian-hormone-in-the-ovarian-cycle
#20
Narelle Hadlow, Suzanne J Brown, Afsana Habib, Robert Wardrop, John Joseph, Melissa Gillett, Rhonda Maguire, Johan Conradie
OBJECTIVE: To quantify intraindividual variability of antimüllerian hormone (AMH) as analytical and biological coefficients of variation and assess the effects of variation on clinical classification. DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): Thirty-eight women referred by general practitioners. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Total intraindividual variability (CVW), analytical (CVA) and biological variability (CVI) for each woman and for AMH ranges: low (<5 pmol/L), reduced (5-10), moderate (>10-30) and high (>30 pmol/L), with calculation of proportion of women crossing clinical cutoffs and expected variability around each cutoff...
June 25, 2016: Fertility and Sterility
keyword
keyword
108343
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"